Background/Aims: Carney complex (CNC) is a rare syndrome associated with multiple tumors and several other unique manifestations. We describe the clinical, genetic, and laboratory findings in a cohort of patients with CNC and failure to thrive (FTT). Methods: A retrospective case series of pediatric patients with CNC presenting with FTT. Results: We describe a patient with infantile Cushing syndrome (CS) who presented with severe FTT and liver disease; the patient was subsequently diagnosed with CNC. This led to the realization that at least 10 other patients with CNC and FTT have been investigated in the last 22 years at the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Four of those had primary pigmented nodular adrenocortical disease (PPNAD), 2 had cardiac myxomas, and 3 had liver disease. Conclusion: Pediatric patients with CNC may present with FTT whose primary cause is variable and includes CS due to PPNAD, hepatic involvement, and other manifestations of CNC. FTT due to liver disease and/or other causes is a unique new presentation of this rare syndrome with which clinicians need to be familiar.

Keywords:
Carney complex, Failure to thrive, Liver disease
1.
Stratakis CA, Kirschner LS, Carney JA, Pack SD, Taymans SE, Giatzakis C, et al: Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet 2000; 26: 89–92.
2.
Correa R, Salpea P, Stratakis CA: Carney complex: an update. Eur J Endocrinol 2015; 173:M85–M97.
3.
Stratakis CA: Carney complex: A familial lentiginosis predisposing to a variety of tumors. Rev Endocr Metab Disord 2016; 17: 367–371.
4.
Courcoutsakis NA, Tatsi C, Patronas NJ, et al: The complex of myxomas, spotty skin pigmentation and endocrine overactivity (Carney complex): imaging findings with clinical and pathological correlation. Insights Imaging 2013; 4: 119–133.
5.
Espiard S, Bertherat J: Carney complex. Front Horm Res 2013; 41: 50–62.
6.
Bertherat J, Horvath A, Groussin L, Grabar S, Boikos S, Cazabat L, et al: Mutations in regulatory subunit type 1A of cyclic adenosine 5′-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes. J Clin Endocrinol Metab 2009; 94: 2085–2091.
7.
Perrin EC, Cole CH, Frank DA, Glicken SR, Guerina N, Petit K, et al: Criteria for determining disability in infants and children: failure to thrive. Evid Rep Technol Assess (Summ) 2003; 72: 1–5.
8.
Daniel M, Kleis L, Cemeroglu AP: Etiology of failure to thrive in infants and toddlers referred to a pediatric endocrinology outpatient clinic. Clin Pediatr (Phila) 2008; 47: 762–765.
9.
Pandya AN, Boorman JG: Failure to thrive in babies with cleft lip and palate. Br J Plast Surg 2001; 54: 471–475.
10.
Gennari M, Stratakis CA, Hovarth A, Pirazzoli P, Cicognani A: A novel PRKAR1A mutation associated with hepatocellular carcinoma in a young patient and a variable Carney complex phenotype in affected subjects in older generations. Clin Endocrinol (Oxf) 2008; 69: 751–755.
11.
Terracciano LM, Tornillo L, Avoledo P, Von Schweinitz D, Kühne T, Bruder E: Fibrolamellar hepatocellular carcinoma occurring 5 years after hepatocellular adenoma in a 14-year-old girl: a case report with comparative genomic hybridization analysis. Arch Pathol Lab Med 2004; 128: 222–226.
12.
Veugelers M, Wilkes D, Burton K, McDermott DA, Song Y, Goldstein MM, et al: Comparative PRKAR1A genotype-phenotype analyses in humans with Carney complex and prkar1a haploinsufficient mice. Proc Natl Acad Sci 2004; 101: 14222–14227.
13.
Saloustros E, Salpea P, Starost M, Liu S, Faucz FR, London E, et al: Prkar1a gene knockout in the pancreas leads to neuroendocrine tumorigenesis. Endocr Relat Cancer 2017; 24: 31–40.
14.
Gaujoux S, Tissier F, Ragazzon B, Rebours V, Saloustros E, Perlemoine K, et al: Pancreatic ductal and acinar cell neoplasms in carney complex: a possible new association. J Clin Endocrinol Metab 2011; 96:E1888–E1895.
15.
Heilskov S, Rytter MJH, Vestergaard C, Briend A, Babirekere E, Deleuran MS: Dermatosis in children with oedematous malnutrition (Kwashiorkor): a review of the literature. J Eur Acad Dermatol Venereol 2014; 28: 995–1001.
16.
Paes EC, de Vries IAC, Penris WM, Hanny KH, Lavrijsen SW, van Leerdam EK, et al: Growth and prevalence of feeding difficulties in children with Robin sequence: a retrospective cohort study. Clin Oral Investig 2017; 21: 2063–2076.
17.
Scott A: Surgical management of Pierre Robin sequence: using mandibular distraction osteogenesis to address hypoventilation and failure to thrive in infancy. Facial Plast Surg 2016; 32: 177–187.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.